A 6605 (see companion bill S 5401) – New York

Status: In Process
Year Introduced: 2021
Link: https://www.nysenate.gov/legislation/bills/2021/A6605

Provides that the price of single source brand-name maintenance medication for which there is no National Average Drug Acquisition Cost pricing shall be the wholesale acquisition cost.


Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found